European Biotech: EU Commission Defines Innovative Enterprises to Unlock Investment

The Commission's new recommendation on defining innovative enterprises and startups aims to streamline public support and attract private capital to Europe's biotech and deep tech sectors.

Europe's Innovation Engine: How a New Definition Will Unlock Billions for Deep Tech

The European Commission's Recommendation (EU) 2026/720, published March 18, establishes a formal definition of innovative enterprises, innovative startups, and innovative scaleups that is expected to have significant practical implications for how public and private capital reaches European technology companies, particularly in biotech, deep tech, and industrial technology sectors where the European ecosystem has historically been strongest in research but weakest in commercialisation.

The definition framework addresses a persistent problem in European innovation policy: the word 'innovative' is used so broadly in policy documents, tax codes, and public support programmes that it has lost practical meaning. Companies of every description claim to be innovative; public support administrators lack clear criteria to distinguish genuinely innovation-intensive enterprises from those that adopt the label for eligibility purposes. By establishing common criteria for innovation intensity — covering research and development expenditure ratios, novelty of technology or business model, and growth orientation — the recommendation gives member state administrations a shared framework for targeting support effectively.

European biotech in particular has been identified as a sector where the definition matters enormously. The EU produces world-class biomedical research but has historically struggled to translate that research into companies that can compete with American biotech firms in the scale and speed of their development trajectories. The venture-backed model that has powered US biotech success requires investors to identify genuinely innovative companies efficiently, and a clearer common definition reduces the due diligence burden and creates more consistency in how public and private support programmes interact with the sector.